NO20022739D0 - Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser - Google Patents
Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelserInfo
- Publication number
- NO20022739D0 NO20022739D0 NO20022739A NO20022739A NO20022739D0 NO 20022739 D0 NO20022739 D0 NO 20022739D0 NO 20022739 A NO20022739 A NO 20022739A NO 20022739 A NO20022739 A NO 20022739A NO 20022739 D0 NO20022739 D0 NO 20022739D0
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- treatment
- dioxino
- neuroleptics
- benzylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45860799A | 1999-12-10 | 1999-12-10 | |
PCT/US2000/033060 WO2001041750A2 (en) | 1999-12-10 | 2000-12-07 | Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022739L NO20022739L (no) | 2002-06-07 |
NO20022739D0 true NO20022739D0 (no) | 2002-06-07 |
Family
ID=23821437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022739A NO20022739D0 (no) | 1999-12-10 | 2002-06-07 | Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1235570A2 (ko) |
JP (1) | JP5557409B2 (ko) |
KR (1) | KR100772854B1 (ko) |
CN (1) | CN1230164C (ko) |
AR (1) | AR026756A1 (ko) |
AU (1) | AU784211B2 (ko) |
BR (1) | BR0016168A (ko) |
CA (1) | CA2396351C (ko) |
CZ (1) | CZ20021880A3 (ko) |
EA (1) | EA005002B1 (ko) |
HK (1) | HK1045942A1 (ko) |
HU (1) | HUP0203309A3 (ko) |
IL (2) | IL149669A0 (ko) |
MX (1) | MXPA02005649A (ko) |
NO (1) | NO20022739D0 (ko) |
NZ (1) | NZ519381A (ko) |
PL (1) | PL355292A1 (ko) |
TW (1) | TWI222864B (ko) |
WO (1) | WO2001041750A2 (ko) |
ZA (1) | ZA200205484B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06004752A (es) | 2003-10-29 | 2006-07-05 | Wyeth Corp | Composiciones farmaceuticas de liberacion mantenida que contienen aplindore y sus derivados. |
AR052674A1 (es) | 2005-02-17 | 2007-03-28 | Wyeth Corp | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados |
PL2254598T3 (pl) * | 2008-02-13 | 2013-12-31 | Targacept Inc | Połączenie agonistów receptorów nikotynowych alfa 7 i środków przeciwpsychotycznych |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2987484B2 (ja) * | 1995-03-16 | 1999-12-06 | 大塚製薬 株式会社 | カルボスチリル誘導体の製造方法 |
US5756532A (en) * | 1995-11-06 | 1998-05-26 | American Home Products Corporation | Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives |
GB9627005D0 (en) * | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
-
2000
- 2000-12-07 WO PCT/US2000/033060 patent/WO2001041750A2/en active IP Right Grant
- 2000-12-07 JP JP2001543095A patent/JP5557409B2/ja not_active Expired - Lifetime
- 2000-12-07 AR ARP000106504A patent/AR026756A1/es unknown
- 2000-12-07 CN CNB008169527A patent/CN1230164C/zh not_active Expired - Lifetime
- 2000-12-07 EP EP00982461A patent/EP1235570A2/en not_active Withdrawn
- 2000-12-07 BR BR0016168-3A patent/BR0016168A/pt not_active Application Discontinuation
- 2000-12-07 EA EA200200656A patent/EA005002B1/ru not_active IP Right Cessation
- 2000-12-07 IL IL14966900A patent/IL149669A0/xx active IP Right Grant
- 2000-12-07 AU AU19490/01A patent/AU784211B2/en not_active Ceased
- 2000-12-07 NZ NZ519381A patent/NZ519381A/en unknown
- 2000-12-07 CZ CZ20021880A patent/CZ20021880A3/cs unknown
- 2000-12-07 HU HU0203309A patent/HUP0203309A3/hu unknown
- 2000-12-07 CA CA002396351A patent/CA2396351C/en not_active Expired - Lifetime
- 2000-12-07 MX MXPA02005649A patent/MXPA02005649A/es active IP Right Grant
- 2000-12-07 KR KR1020027007286A patent/KR100772854B1/ko not_active IP Right Cessation
- 2000-12-07 PL PL00355292A patent/PL355292A1/xx not_active Application Discontinuation
- 2000-12-08 TW TW089126071A patent/TWI222864B/zh not_active IP Right Cessation
-
2002
- 2002-05-15 IL IL149669A patent/IL149669A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022739A patent/NO20022739D0/no not_active Application Discontinuation
- 2002-07-09 ZA ZA200205484A patent/ZA200205484B/xx unknown
- 2002-10-09 HK HK02107378.5A patent/HK1045942A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR100772854B1 (ko) | 2007-11-02 |
CA2396351A1 (en) | 2001-06-14 |
AU784211B2 (en) | 2006-02-23 |
CA2396351C (en) | 2009-11-10 |
HK1045942A1 (zh) | 2002-12-20 |
CN1230164C (zh) | 2005-12-07 |
MXPA02005649A (es) | 2004-09-10 |
CN1409633A (zh) | 2003-04-09 |
EA200200656A1 (ru) | 2002-12-26 |
IL149669A0 (en) | 2002-11-10 |
JP2003516350A (ja) | 2003-05-13 |
WO2001041750A2 (en) | 2001-06-14 |
EA005002B1 (ru) | 2004-10-28 |
KR20030016207A (ko) | 2003-02-26 |
HUP0203309A2 (hu) | 2003-01-28 |
NO20022739L (no) | 2002-06-07 |
AU1949001A (en) | 2001-06-18 |
EP1235570A2 (en) | 2002-09-04 |
BR0016168A (pt) | 2002-08-20 |
NZ519381A (en) | 2004-04-30 |
AR026756A1 (es) | 2003-02-26 |
WO2001041750A3 (en) | 2002-02-14 |
IL149669A (en) | 2006-06-11 |
HUP0203309A3 (en) | 2004-12-28 |
ZA200205484B (en) | 2003-12-31 |
TWI222864B (en) | 2004-11-01 |
CZ20021880A3 (cs) | 2002-08-14 |
PL355292A1 (en) | 2004-04-05 |
JP5557409B2 (ja) | 2014-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
TWI265808B (en) | Valdecoxib compositions | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
EP1259240B8 (en) | Agents, such as nicotinamide or cadpr for the treatment of skin disorders | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
NO306779B1 (no) | Naftalamider, anvendelse derav og farmasöytisk preparat | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
ES2173887T3 (es) | Nuevos usos farmaceuticos de las enzimas de krill. | |
TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
IT1264530B (it) | Impiego dei polisaccaridi nelle neuropatie atrofico degenerative | |
SE9802208D0 (sv) | Novel compounds | |
MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
DE69939075D1 (de) | Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten | |
SE0001916D0 (sv) | Novel formulation | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
NO20022739D0 (no) | Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser | |
JO2199B1 (en) | Replaced pyrrols | |
WO2002076930A3 (en) | Substituted diarylureas as stimulators for fas-mediated apoptosis | |
TR199901385T2 (xx) | Piperidin t�revleri. | |
WO2003080568A3 (en) | Probucol derivatives | |
AU3992897A (en) | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders | |
ITMI20020872A1 (it) | Derivati dell'iperforina loro uso e formulazioni che li contengono | |
JO2296B1 (en) | Substituted pyrolates | |
EP1878728A3 (en) | Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |